Accord Healthcare £603 million acquisition of UK and Ireland assets of Actavis Generics

6/10/2016

Public acquisition

Value:

£ 603 million

Dollar value:

$ 740.393 million

Status:

Announced

Date:

6/10/2016

Overview:

Accord Healthcare is set to acquire the UK and Ireland assets of Actavis Generics for £603 million from Teva.
Accord is a subsidiary of Indian drug-maker Intas.
The deal is part of Teva's divestment strategy in order to gain competition clearance for its acquisition of Allergan's generic's business.
Actavis was renamed Allergan in 2015.

Sam Duke - Editor

Jurisdictions:

India
Ireland
United Kingdom

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Linklaters

Party: Accord Healthcare (Acquirer)

Party: Intas Pharmaeuticals (Acquirer)

Lawyers: James Inglis, Narayan Iyer

Osborne Clarke

Party: Actavis (Target)

Pinsent Masons

Party: Teva Pharmaceuticals (Seller)

Lawyer: Andrew Hornigold

Related deals